Skip to main content
Autobound logo
BriaCell Therapeutics Corp.SEC 10-K

BriaCell reports negative operating cash flow of $28.65 million with substantial doubt on going concern

Read at SEC EDGAR

What happened

5 signals in this filing. Net cash used in operating activities reached $28,651,323 for the year ended July 31, 2026, alongside an accumulated deficit of $146,659,826. This ongoing cash burn and going-concern uncertainty indicates the company...

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 10-K

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Oct 28, 2026

More SEC 10-K signals at other companies

The full record

From the Signal API record

Numbers

Dollar figurenet cash used in operating activities for the year ended July 31, 2026
$28.7M

Details

CIK
1610820
Accession number
0001493152-26-049041
Timeframe
Current year
Filing year
2026
Why it matters
Treasury/cash management needs
Signal category
Financial

Extraction

Confidence
High
Relevance
85%
Sentiment
Negative
Detected
Nov 3, 2026
signal_type
sec-10k
signal_subtype
cashFlowConcern

Use this data

Get every SEC 10-K signal for BriaCell Therapeutics Corp. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at BriaCell Therapeutics Corp. this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns SEC 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/c89ed20b-aa6b-4ab7-8ce3-948d5c9a38ba returns this record as JSON. POST /v1/companies/enrich returns every signal for briacell.com.

{
  "signal_id": "c89ed20b-aa6b-4ab7-8ce3-948d5c9a38ba",
  "signal_type": "sec-10k",
  "signal_subtype": "cashFlowConcern",
  "detected_at": "2026-11-03T07:03:48.755+00:00",
  "company": {
    "name": "BriaCell Therapeutics Corp.",
    "domain": "briacell.com"
  },
  "data": {
    "detail": "Net cash used in operating activities reached $28,651,323 for the year ended July 31, 2026, alongside an accumulated deficit of $146,659,826. This ongoing cash burn and going-concern uncertainty indicates the company may urgently require external capital, financing solutions, or clinical efficiency platforms.",
    "metrics": {
      "timeframe": "current_year",
      "dollar_context": "net cash used in operating activities for the year ended July 31, 2026",
      "dollar_millions": 28.651323
    },
    "summary": "BriaCell reports negative operating cash flow of $28.65 million with substantial doubt on going concern",
    "relevance": 0.85,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1610820/000149315226049041/form10-k.htm",
    "filing_date": "2026-10-28",
    "filing_year": 2026,
    "sales_relevance": "Treasury/cash management needs",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.